BPR-221-008
/ Chengdu Brilliant Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 16, 2026
A Novel Biased GLP-1R/Amylin Receptor Dual Agonist BPR-221-008 and Once-Monthly Formulation in Obese Rats
(OBESITY WEEK 2026)
- No abstract available
Preclinical • Obesity
1 to 1
Of
1
Go to page
1